Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naim Alkhouri

Showing results (81-90 of 306) with videos related to

Pageof 31
Sort By:
Digestive Diseases and Sciences|July 17, 2010
Ileoscopy via stoma after diverting ileostomy: a safe and effective tool to evaluate for Crohn's recurrence of neoterminal ileumNarendra Vadlamudi, Naim Alkhouri, Lori Mahajan, et al.
Expert Opinion on Investigational Drugs|January 21, 2022
Nonalcoholic steatohepatitis (NASH) cirrhosis: a snapshot of therapeutic agents in clinical development and the optimal design for clinical trialsPankaj Aggarwal, Mazen Noureddin, Stephen Harrison, et al.
Inflammatory Bowel Diseases|December 17, 2009
Low-dose naltrexone for treatment of duodenal Crohn's disease in a pediatric patientAngela Shannon, Naim Alkhouri, Shadi Mayacy, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 10, 2014
A non-invasive prediction model for non-alcoholic steatohepatitis in paediatric patients with non-alcoholic fatty liver diseaseKatharine Eng, Rocio Lopez, Daniela Liccardo, et al.
Alimentary Pharmacology & Therapeutics|February 24, 2024
Letter: Severe underweight and sarcopenia in decompensated cirrhosis are associated with high FGF21 levels-authors' replyNaim Alkhouri, Leo Tseng, Kemal Balic, et al.
Current Pediatric Reviews|August 5, 2014
Nonalcoholic fatty liver disease in children: recent practice guidelines, where do they take us?Ashish Aggarwal, Kanika Puri, Suraj Thangada, et al.
World Journal of Clinical Cases|December 5, 2013
Hepatitis C treatment with triple therapy in a patient with hemophilia AGurshawn Singh, Reuben Sass, Rayan Alamiry, et al.
Clinical Lipidology|December 14, 2011
Atherogenic dyslipidemia and cardiovascular risk in children with nonalcoholic fatty liver diseaseNaim Alkhouri, Christine Carter-Kent, Michael Elias, et al.
Gastro Hep Advances|June 15, 2026
Breath-Based Diagnostics in Liver Diseases: Dynamic Assessment of Hepatic Metabolic Reserve and Liver FibrosisNazli Begum Ozturk, Kamran Qureshi, Wing-Kin Syn, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 28, 2010
Monitoring peripheral blood CD4+ adenosine triphosphate activity in recurrent hepatitis C and its correlation to fibrosis progressionNaim Alkhouri, Ibrahim A Hanouneh, Rocio Lopez, et al.
Pageof 31

Showing results (81-90 of 306) with videos related to

Sort By:
Pageof 31
Digestive Diseases and Sciences|July 17, 2010
Ileoscopy via stoma after diverting ileostomy: a safe and effective tool to evaluate for Crohn's recurrence of neoterminal ileumNarendra Vadlamudi, Naim Alkhouri, Lori Mahajan, et al.
Expert Opinion on Investigational Drugs|January 21, 2022
Nonalcoholic steatohepatitis (NASH) cirrhosis: a snapshot of therapeutic agents in clinical development and the optimal design for clinical trialsPankaj Aggarwal, Mazen Noureddin, Stephen Harrison, et al.
Inflammatory Bowel Diseases|December 17, 2009
Low-dose naltrexone for treatment of duodenal Crohn's disease in a pediatric patientAngela Shannon, Naim Alkhouri, Shadi Mayacy, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 10, 2014
A non-invasive prediction model for non-alcoholic steatohepatitis in paediatric patients with non-alcoholic fatty liver diseaseKatharine Eng, Rocio Lopez, Daniela Liccardo, et al.
Alimentary Pharmacology & Therapeutics|February 24, 2024
Letter: Severe underweight and sarcopenia in decompensated cirrhosis are associated with high FGF21 levels-authors' replyNaim Alkhouri, Leo Tseng, Kemal Balic, et al.
Current Pediatric Reviews|August 5, 2014
Nonalcoholic fatty liver disease in children: recent practice guidelines, where do they take us?Ashish Aggarwal, Kanika Puri, Suraj Thangada, et al.
World Journal of Clinical Cases|December 5, 2013
Hepatitis C treatment with triple therapy in a patient with hemophilia AGurshawn Singh, Reuben Sass, Rayan Alamiry, et al.
Clinical Lipidology|December 14, 2011
Atherogenic dyslipidemia and cardiovascular risk in children with nonalcoholic fatty liver diseaseNaim Alkhouri, Christine Carter-Kent, Michael Elias, et al.
Gastro Hep Advances|June 15, 2026
Breath-Based Diagnostics in Liver Diseases: Dynamic Assessment of Hepatic Metabolic Reserve and Liver FibrosisNazli Begum Ozturk, Kamran Qureshi, Wing-Kin Syn, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 28, 2010
Monitoring peripheral blood CD4+ adenosine triphosphate activity in recurrent hepatitis C and its correlation to fibrosis progressionNaim Alkhouri, Ibrahim A Hanouneh, Rocio Lopez, et al.
Pageof 31